Infinium Omni2.5Exome-8

Infinium Omni2.5Exome-8 v1.3 (8-sample)

The 8-sample Infinium Omni2.5Exome-8 Beadchip combines >2.5 million tag SNPs form the Hapmap and 1000 Genomes projects (>2.5%MAF) with >240,000 markers from the Infinium Exome-24 BeadChip. These combined markers allow researchers to gain insight into whole-genome variation while maximizing coverage of functional exonic SNPs.

Order Now  Support  Training

Please rotate your device for details

Product Information*
Total No. of Markers 2,612,357
Capacity for Custom Bead Types –
No. of Samples per BeadChip 8
DNA Input Requirement 200 ng
Assay Chemistry Infinium LCG
FFPE compatible Yes
Spacing (kb) Mean Median 90th%
1.12 0.56 2.63
Number of SNPs within 10kb of RefSeq genes 1,505,218
Exonic Markers 364,396

*Please see the Data Sheet for additional product specifications.

LD Coverage (%, r2>0.8) from 1kGP
Population MAF >1% MAF >2.5% MAF >5% 
AFR 0.54 0.64 0.69
AMR 0.74 0.82 0.86
EAS 0.79 0.86 0.89
EUR 0.79 0.86 0.89
SAS 0.75 0.83 0.87
Product and Ordering Information
  • Infinium Omni2.5Exome-8 v1.3 BeadChip Kits: 20003583 (16 samples), 20003606 (48 samples), 20003607 (96 samples), 20003608 (384 samples)
  • Infinium Omni2.5Exome-8 Product Page
Support Links
Order Now  Support  Training
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.